Pfizer Inc. has said it will discontinue development of its closely watched obesity pill, danuglipron, dealing a severe blow to the company’s ambitions to...
A potential breakthrough in cardiovascular medicine has emerged with the development of lepodisiran, an experimental drug by pharmaceutical company Eli Lilly.The drug has demonstrated...
Mounjaro, an injectable medication designed to support weight loss, works by imitating the effects of two natural hormones, GLP-1 and GIP, which help control...
India’s wait is over.The popular anti-obesity drug Mounjaro is finally here.The development comes after Eli Lilly received approval from India’s Central Drugs Standard Control...
Increased manufacturing capacity for Eli Lilly’s highly sought after weight-loss drug Zepbound drove the company to raise its annual sales forecast by $3 billion...